Siobhan H. O'Brien

Person

London, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Chimeric antibodies for treatment of amyloid deposition diseases
- Patent number 11,530,257
- Issue date Dec 20, 2022
- Tarran Jones
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 8,926,971
- Issue date Jan 6, 2015
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 8,227,211
- Issue date Jul 24, 2012
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 7,566,450
- Issue date Jul 28, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 7,473,421
- Issue date Jan 6, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 7,442,775
- Issue date Oct 28, 2008
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant anti-CCR2 antibodies and methods of use therefor
- Patent number 6,727,349
- Issue date Apr 27, 2004
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CCR2 antibodies and methods of use therefor
- Patent number 6,696,550
- Issue date Feb 24, 2004
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CHIMERIC ANTIBODIES FOR TREATMENT OF AMYLOID DEPOSITION DISEASES
- Publication number 20230212273
- Publication date Jul 6, 2023
- THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
- Tarran Jones
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIBODIES FOR TREATMENT OF AMYLOID DEPOSITION DISEASES
- Publication number 20200181246
- Publication date Jun 11, 2020
- THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
- Tarran Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR
- Publication number 20150086546
- Publication date Mar 26, 2015
- Millennium Pharmaceuticals, Inc.
- Gregory J. Larosa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR
- Publication number 20130071381
- Publication date Mar 21, 2013
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR
- Publication number 20090191192
- Publication date Jul 30, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20090169541
- Publication date Jul 2, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20090142339
- Publication date Jun 4, 2009
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20080268536
- Publication date Oct 30, 2008
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20080241136
- Publication date Oct 2, 2008
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
- Publication number 20080241923
- Publication date Oct 2, 2008
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized anti-CCR2 antibodies and methods of use therefor
- Publication number 20040132980
- Publication date Jul 8, 2004
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized anti-CCR2 antibodies and methods of use therefor
- Publication number 20040126851
- Publication date Jul 1, 2004
- Millennium Pharmaceuticals, Inc.
- Gregory J. LaRosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized anti-CCR2 antibodies and methods of use therefor
- Publication number 20020150576
- Publication date Oct 17, 2002
- Gregory J. LaRosa
- C07 - ORGANIC CHEMISTRY

Siobhan H. O'Brien

Person

Patents Grantslast 30 patents

Chimeric antibodies for treatment of amyloid deposition diseases

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Recombinant anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Patents Applicationslast 30 patents

CHIMERIC ANTIBODIES FOR TREATMENT OF AMYLOID DEPOSITION DISEASES

CHIMERIC ANTIBODIES FOR TREATMENT OF AMYLOID DEPOSITION DISEASES

HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR

HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR

HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Humanized Anti-CCR2 Antibodies and Methods of Use Therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor

Humanized anti-CCR2 antibodies and methods of use therefor